Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Appyea (APYP) Cash & Equivalents (2016 - 2025)

Appyea filings provide 9 years of Cash & Equivalents readings, the most recent being $408000.0 for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 416.46% to $408000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $408000.0, a 416.46% increase, with the full-year FY2025 number at $408000.0, up 416.46% from a year prior.
  • Cash & Equivalents reached $408000.0 in Q4 2025 per APYP's latest filing, down from $468000.0 in the prior quarter.
  • The five-year high for Cash & Equivalents was $468000.0 in Q3 2025, with the low at $8000.0 in Q2 2025.